230 related articles for article (PubMed ID: 6614958)
1. Topically administered fluorouracil in vitiligo.
Tsuji T; Hamada T
Arch Dermatol; 1983 Sep; 119(9):722-7. PubMed ID: 6614958
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo.
Sethi S; Mahajan BB; Gupta RR; Ohri A
Int J Dermatol; 2007 Aug; 46(8):875-9. PubMed ID: 17651178
[TBL] [Abstract][Full Text] [Related]
3. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
4. Pimecrolimus cream in repigmentation of vitiligo.
Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
[TBL] [Abstract][Full Text] [Related]
5. Repigmentation of vitiligo macules treated topically with Efudix cream.
Szekeres E; Morvay M
Dermatologica; 1985; 171(1):55-9. PubMed ID: 4029463
[TBL] [Abstract][Full Text] [Related]
6. Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus.
Lubaki LJ; Ghanem G; Vereecken P; Fouty E; Benammar L; Vadoud-Seyedi J; Dell'Anna ML; Briganti S; Picardo M; Heenen M
Arch Dermatol Res; 2010 Mar; 302(2):131-7. PubMed ID: 19547993
[TBL] [Abstract][Full Text] [Related]
7. Combination of microdermabrasion and 5-fluorouracil to induce repigmentation in vitiligo: an observational study.
Garg T; Chander R; Jain A
Dermatol Surg; 2011 Dec; 37(12):1763-6. PubMed ID: 21834930
[TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus for treatment of childhood vitiligo in Asians.
Kanwar AJ; Dogra S; Parsad D
Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
[TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
10. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
Hartmann A; Bröcker EB; Hamm H
J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
[TBL] [Abstract][Full Text] [Related]
12. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
[TBL] [Abstract][Full Text] [Related]
13. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
Westerhof W; Nieuweboer-Krobotova L
Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
[TBL] [Abstract][Full Text] [Related]
14. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
[TBL] [Abstract][Full Text] [Related]
15. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
[TBL] [Abstract][Full Text] [Related]
16. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
Hartmann A; Bröcker EB; Hamm H
Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
18. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
Kumaran MS; Kaur I; Kumar B
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo.
Sanclemente G; Garcia JJ; Zuleta JJ; Diehl C; Correa C; Falabella R
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1359-64. PubMed ID: 18624857
[TBL] [Abstract][Full Text] [Related]
20. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
